Can a smartphone app ease the burden of advanced lung cancer?

NCT ID NCT06427954

First seen Jul 13, 2026 · Last updated Jul 14, 2026 · Updated 1 time

Summary

This study tests whether a mobile app called THRIVE can help people with newly diagnosed advanced lung cancer feel better day-to-day. Researchers will compare quality of life, physical and emotional symptoms, and coping skills between app users and those receiving usual care. The goal is to see if a simple digital tool can make a real difference in managing life with advanced cancer.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
THRIVE digital health application
What this could lead to
If effective, the app could offer a simple, scalable way to help people with advanced lung cancer feel better and manage symptoms at home.
What could go wrong
This is a behavioral intervention, not a treatment for the cancer itself. Results depend on how consistently participants use the app, and benefits may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED NON SMALL CELL LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Massachusetts General Hospital

    RECRUITING

    Boston, Massachusetts, 02114, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • University of California Los Angeles

    RECRUITING

    Los Angeles, California, 90024, United States

    Contact Email: •••••@•••••

  • Veteran Affairs Greater Los Angeles Health Care

    NOT_YET_RECRUITING

    Los Angeles, California, 90073, United States

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.